UnitedHealthcare, Humana, Aetna scale back Medicare Advantage plans for 2026

The CMS's 2026 Medicare Advantage (MA) plan data reveals that the three largest carriers—UnitedHealthcare, Humana, and Aetna—are significantly curtailing their state and county footprints to bolster flagging margins, which have been pressured by higher utilization and reimbursement changes. This strategic retrenchment will force potentially over a million seniors to re-evaluate their coverage, likely encountering higher average premiums (up ~22% for general enrollment), increased deductibles, reduced benefits, and a shift towards more restrictive HMO plans. While creating growth opportunities for smaller regional players, this shift signals a focus on profitability by major insurers and is projected to lead to the first year-over-year decrease in overall MA enrollment in two decades, impacting market share and plan design across the industry.

Analysis

The 2026 Medicare Advantage (MA) landscape is undergoing a significant strategic rationalization, driven by the largest carriers prioritizing profitability over growth. UnitedHealthcare (UNH), Humana (HUM), and Aetna (CVS) are actively reducing their geographic footprints—cutting 108, 194, and 98 counties, respectively—in direct response to flagging margins pressured by higher medical utilization and adverse reimbursement changes. This retrenchment by the top three players, who cover nearly 75% of the MA population, creates a growth opportunity for smaller regional carriers and contrarian expansionists like Elevance (ELV) and Centene (CNC), which are modestly increasing their county presence. While the average number of plans available per county remains stable at 41.9, this figure masks a fundamental shift in plan economics for consumers. For the core general enrollment population, average monthly premiums are projected to rise by nearly 22% ($2.84), according to a Morgan Stanley analysis. Concurrently, insurers are implementing less visible cost-saving measures, including higher deductibles, increased out-of-pocket maximums, a pivot to more restrictive HMO plans, and material cuts to benefits like over-the-counter allowances. This industry-wide focus on margin recovery is expected to cause significant disruption, forcing potentially over a million seniors to find new plans and resulting in the first projected year-over-year decline in total MA enrollment in two decades, a development that could push MA penetration back below 50% of all Medicare beneficiaries.

Key Decisions for Investors

• Investors in UnitedHealthcare, Humana, and CVS should monitor for evidence of margin improvement in upcoming quarters, as this geographic pullback is a deliberate trade-off of enrollment growth for profitability.
• Consider the potential for market share gains at Elevance and Centene, which are positioned to capture members displaced by competitors; their enrollment figures following the open enrollment period will be a key performance indicator.
• Re-evaluate long-term growth assumptions for the MA sector, as the first projected enrollment decline in 20 years signals a potential market maturation and a strategic shift from scale to profitability.
• Be aware of headline and regulatory risk, as the combination of rising premiums, reduced benefits, and plan disruption could attract negative attention and impact member retention across the industry.